However, there is limited clinical experience with dulaglutide in liver disease so caution should be used
At Batley Pharmacy, we keep a close eye on the latest regulatory updates so we can offer our patients the most modern, approved treatments
Conclusion GLP-1 RAs show promise as a disease-modifying therapy for IIH, with potential benefits beyond weight loss
It points to roughly six months or more since surgery as the window providers typically prefer, on the reasoning that metabolic changes need time to stabilize
New treatment options bring hope to the many people with obesity who struggle with this disease and are seeking better options for weight management. The approval was based on results from the phase III SURMOUNT-1 and SURMOUNT-2 trials
Now, alarmed by sunken features and sagging skin, newly svelte patients are flooding med spas and plastic surgery clinics, desperate to plump, lift and smooth their way back to a youthful glow